Designed coiled-coil peptides inhibit the type three secretion system of enteropathogenic Escherichia coli

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Larzábal, Mariano ^a   Mercado, Elsa C ^a   Vilte, Daniel A ^a   Salazar González, Hector ^b   Cataldi, Angel ^a   Navarro Garcia, Fernando ^b  

^a INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; BACTERIAL PROTEIN; COILD PROTEIN; ESCF PROTEIN; ESCHERICHIA COLI SECRETED PROTEIN A; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; EAEB PROTEIN, E COLI; ESCF PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; ESPA PROTEIN, E COLI; ESPD PROTEIN, E COLI; OUTER MEMBRANE PROTEIN; PEPTIDE;

ARTICLE; BACTERIAL STRAIN; CELL FREE SYSTEM; COILED BODY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIUM CELL; ERYTHROCYTE; GROWTH INHIBITION; HEMOLYSIS; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INCUBATION TIME; POLYMERIZATION; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TRANSPORT; TYPE THREE SECRETION SYSTEM; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI INFECTION; IMMUNOELECTRON MICROSCOPY; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; MOLECULAR GENETICS; SECRETION; SHEEP; SYNTHESIS; TUMOR CELL LINE; ULTRASTRUCTURE; WESTERN BLOTTING;

ESCHERICHIA COLI; MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; ENTEROPATHOGENIC ESCHERICHIA COLI; ERYTHROCYTES; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HEMOLYSIS; HUMANS; MICROBIAL VIABILITY; MICROSCOPY, IMMUNOELECTRON; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN TRANSPORT; SHEEP;

EID: 77949350020     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009046     Document Type: Article

References (46)

1. Nataro JP, Kaper JB (1998) Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
2. Karch H, Tarr PI, Bielaszewska M (2005) Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol 295: 405-18.
3. Repetto HA (2005) Long-term course and mechanisms of progression of renal disease in haemolytic uremic syndrome. Kidney Int Suppl: S102-6.
4. Miliwebsky E, Deza N, Chinen I, Martinez Espinosa E, Gomez D, et al. (2007) Prolonged fecal shedding of Shiga toxin-producing Escherichia coli among children attending day-care centers in Argentina. Rev Argent Microbiol 39: 90-2.
5. Caprioli A, Morabito S, Brugere H, Oswald E (2005) Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 36: 289-311.
6. Gioffre A, Meichtri L, Miliwebsky E, Baschkier A, Chillemi G, et al. (2002) Detection of Shiga toxin-producing Escherichia coli by PCR in cattle in Argentina. Evaluation of two procedures. Vet Microbiol 87: 301-13.
7. Mercado EC, Gioffré A, Rodríguez SM, Cataldi A, Irino K, et al. (2004) Non-O157 Shiga toxin-producing Escherichia coli isolated from diarrhoeic calves in Argentina. J Vet Med B 51: 82-88.
8. Hussein HS, Bollinger LM (2005) Prevalence of Shiga toxin-producing Escherichia coli in beef cattle. J Food Prot 68: 2224-41.
9. McDaniel TK, Jarvis KG, Donnenberg MS, Kaper JB (1995) A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens. Proc Natl Acad Sci USA 92: 1664-8.
10. Wieler LH, McDaniel TK, Whittam TS, Kaper JB (1997) Insertion site of the locus of enterocyte effacement in enteropathogenic and enterohemorrhagic Escherichia coli differs in relation to the clonal phylogeny of the strains. FEMS Microbiol Lett 156: 49-53.
11. Elliott SJ, Wainwright LA, McDaniel TK, Jarvis KG, Deng YK, et al. (1998) The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348/69. Mol Microbiol 28: 1-4.
12. DeVinney R, Gauthier A, Abe A, Finlay BB (1999) Enteropathogenic Escherichia coli: a pathogen that inserts its own receptor into host cells. Cell Mol Life Sci 55: 961-76.
13. Hueck CJ (1998) Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62: 379-433.
14. Vallance BA, Finlay BB (2000) Exploitation of host cells by enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 97: 8799-806.
15. Sekiya K, Ohishi M, Ogino T, Tamanoi K, Sasakawai C, et al. (2001) Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure. Proc Natl Acad Sci USA 98: 11638-43.
16. Kenny B, Lai LC, Finlay BB, Donnenberg MS (1996) EspA, a protein secreted by enteropathogenic Escherichia coli, is required to induce signals in epithelial cells. Mol Microbiol 20: 313-23.
17. Donnenberg MS, Yu J, Kaper JB (1993) A second chromosomal gene necessary for intimate attachment of enteropathogenic Escherichia coli to epithelial cells. J Bacteriol 175: 4670-80.
18. Knutton S, Rosenshine I, Pallen MJ, Nisan I, Neves BC, et al. (1998) A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells. EMBO J 17: 2166-76.
19. Ide T, Laarmann S, Greune L, Schillers H, Oberleithner H, et al. (2001) Characterization of translocation pores inserted into plasma membranes by type III-secreted Esp proteins of enteropathogenic Escherichia coli. Cell Microbiol 3: 669-79.
20. Wolff C, Nisan I, Hanski E, Frankel G, Rosenshine I (1998) Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli. Mol Microbiol 28: 143-155.
21. Nougayrède JP, Fernandes PJ, Donnenberg MS (2003) Adhesion of enteropathogenic Escherichia coli to host cells. Cell Microbiol 5: 359-72.
22. Wilson RK, Shaw RK, Daniell S, Knutton S, Frankel G (2001) Role of EscF, a putative needle complex protein, in the type III protein translocation system of enteropathogenic Escherichia coli. Cell Microbiol 3: 753-762.
23. Kenny B, DeVinney R, Stein M, Reinscheid DJ, Frey EA, et al. (1997) Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells. Cell 91: 511-20.
24. Wall D, Kaiser D (1999) Type IV pili and cell motility. Mol Microbiol 32: 1-10.
25. Delahay RM, Frankel G (2002) Coiled-coil proteins associated with type III secretion systems: a versatile domain revisited. Mol Microbiol 45: 905-16.
26. Delahay RM, Knutton S, Shaw RK, Hartland EL, Pallen MJ, et al. (1999) The coiled-coil domain of EspA is essential for the assembly of the type III secretion translocon on the surface of enteropathogenic Escherichia coli. J Biol Chem 274: 35969-74.
27. Daniell SJ, Delahay RM, Shaw RK, Hartland EL, Pallen MJ, et al. (2001) Coiled-coil domain of enteropathogenic Escherichia coli type III secreted protein EspD is involved in EspA filament-mediated cell attachment and hemolysis. Infect Immun 69: 4055-64.
28. Liu H, Radhakrishnan P, Magoun L, Prabu M, Campellone KG, et al. (2002) Point mutants of EHEC intimin that diminish Tir recognition and actin pedestal formation highlight a putative Tir binding pocket. Mol Microbiol 45: 1557-73.
29. Goldschmidt RM, Macielag MJ, Hlasta DJ, Barrett JF (1997) Inhibition of virulence factors in bacteria. Curr Pharm Des 3: 125-142.
30. Alksne LE, Projan SJ (2000) Bacterial virulence as a target for antimicrobial chemotherapy. Curr Opin Biotechnol 11: 625-636.
31. Marra A (2006) Targeting virulence for antibacterial chemotherapyidentifying and characterizing virulence factors for lead discovery. Drugs R&D 7: 1-16.
32. Burbaum JJ, Sigal NH (1997) New technologies for high-throughput screening. Curr Opin Chem Biol 1: 72-78.
33. Hung DT, Shakhnovich EA, Pierson E, Mekalanos JJ (2005) Small molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310: 670-674.
34. Kauppi AM, Nordfelth R, Hagglund U, Wolf-Watz H, Elofsson M (2003a) Salicylanilides are potent inhibitors of type III secretion in Yersinia. Adv Exp Med Biol 529: 97-100.
35. Kauppi AM, Nordfelth R, Uvell H, Wolf-Watz H, Elofsson M (2003b) Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol 10: 241-9.
36. Gauthier A, Robertson ML, Lowden M, Ibarra JA, Puente JL, et al. (2005) Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob Agents Chemother 49: 4101-9.
37. Muschiol S, Bailey L, Gylfe A, Sundin C, Hultenby K, et al. (2006) A smallmolecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci USA 103: 14566-7.
38. Negrea A, Bjur E, Ygberg SE, Elofsson M, Wolf-Watz H, et al. (2007) Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother 51: 2867-2876.
39. Dahlgren MK, Kauppi AM, Olsson IM, Linusson A, Elofsson M (2007) Design, Synthesis, and Multivariate Quantitative Structure-Activity Relationship of Salicylanilides Potent Inhibitors of Type III Secretion in Yersinia. J Med Chem 50: 6177-6188.
40. Wachter C, Beinke C, Mattes M, Schmidt MA (1999) Insertion of EspD into epithelial target cell membranes by infecting Enteropathogenic Escherichia coli. Mol. Microbiol 31: 1695-1707.
41. Hartland EL, Daniell SJ, Delahay RM, Neves BC, Wallis T, et al. (2000) The type III protein translocation system of enteropathogenic Escherichia coli involves EspA-EspB protein interactions. Mol Microbiol 35: 1483-1492.
42. Levine MM, Bergquist EJ, Nalin DR, Waterman DH, Hornick RB, et al. (1978) Escherichia coli that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive. Lancet 1(8074): 1119-1122.
43. Jarvis KG, Girón JA, Jerse AE, McDaniel TK, Donnenberg MS, et al. (1995) Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation. Proc Natl Acad Sci U S A 92: 7996-8000.
44. Warawa J, Finlay BB, Kenny B (1999) Type III Secretion- Dependent Hemolytic Activity of Enteropathogenic Escherichia coli. Infect Immun 67: 5538-40.
45. Knutton S, Baldwin T, Williams PH, McNeish AS (1989) Flourescent-actin staining (FAS) test. Infect Immun 57: 1290-8.
46. Vilte DA, Larzábal M, Cataldi AA, Mercado EC (2008) Bovine colostrum contains IgG antibodies against Intimin, EspA and EspB proteins, and inhibits the hemolytic activity mediated by the type three secretion system of attaching and effacing Escherichia coli. Clin Vaccine Immunol 15: 1208-13.